Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

Related Companies

TickerCompanyChg %Mkt Cap
GLPGFGalapagos0%5.1B

Galapagos Company Questions & Answers

Q

How do I buy Galapagos (GLPGF) stock?

A

You can purchase shares of Galapagos (OTC: GLPGF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Galapagos's (GLPGF) main competitors?

A

There are no as such competitors for Galapagos.

Q

What is the target price for Galapagos?

A

There is no analysis for Galapagos

Q

How much is Galapagos (GLPGF) stock ?

A

The stock price for Galapagos (OTC: GLPGF) is $78.25 last updated Fri Apr 30 2021 18:18:13 GMT+0000 (Coordinated Universal Time).

Q

When is the next Galapagos (GLPGF) dividend?

A

There are no upcoming dividends for Galapagos.

Q

When is Galapagos (OTC:GLPGF) reporting earnings?

A

There are no earnings for Galapagos

Q

When is the upcoming split for GLPGF?

A

There is no upcoming split for Galapagos.